Clobetasol Propionate Cream USP 0.05% Recall for cGMP Deviations
Teligent Pharma is recalling all unexpired Clobetasol Propionate Cream USP 0.05% nationwide due to current Good Manufacturing Practice (cGMP) deviations related to discontinuation of the firm's stability study program.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is a cGMP deviation related to discontinuation of stability studies—a manufacturing/procedural issue rather than a confirmed product defect or contamination. No harm to patients has been reported.
Plain-English summary
Teligent Pharma, Inc. is recalling Clobetasol Propionate Cream USP, 0.05% (Emollient) in four package sizes: 15 grams (NDC 52565-094-15), 30 grams (NDC 52565-094-30), 45 grams (NDC 52565-094-45), and 60 grams (NDC 52565-094-60). A total of 105,200 tubes have been distributed nationwide in the USA and Puerto Rico.
The recall is issued because the manufacturer is discontinuing its stability study program, which constitutes a deviation from current Good Manufacturing Practice (cGMP) requirements. All products within their expiration dates are included in this recall.
Consumers who have received this medication should contact their pharmacist or healthcare provider before continuing use. Patients should not discontinue use of their medication without consulting their healthcare provider, as abrupt discontinuation could cause harm. The affected batches and expiration dates are listed with the FDA under recall number D-0671-2022.
The recalled product
- Product
- Clobetasol Propionate Cream USP, 0.05% (Emollient), packaged in a) 15 grams tube, NDC 52565-094-15; b) 30 grams tube, NDC 52565-094-30; c) 45 grams tube, NDC 52565-094-45; d) 60 grams tube, NDC 52565-094-60, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310.
- Manufacturer
- Teligent Pharma, Inc.
- Category
- Drug — Topical Corticosteroid
- Hazard
- cgmp-deviation
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (19)
- Batch: a) 15377
- Exp. 3/31/2022
- 15927
- Exp. 9/30/2022
- 16130
- Exp. 11/30/2022
- b) 15117
- Exp. 2/28/2022
- 16028
- 16945
- Exp. 5/31/2023
- c) 15377
- 16683
- Exp. 5/31/2022
- d) 15116
- 15117
- 16228
- 16348
- Exp. 1/31/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27